125 related articles for article (PubMed ID: 3232520)
1. [Role of mast cells in the etiopathogenesis of nasal polyps].
Bellioni P; Ruscito P; Bevilacqua P; Ciancaglini A; Di Luzio Paparatti U; Maggiano N; Larocca LM
Acta Otorhinolaryngol Ital; 1988; 8(4):371-83. PubMed ID: 3232520
[No Abstract] [Full Text] [Related]
2. Etiology of nasal polyps associated with aspirin-sensitive asthma.
Yamashita T; Tsuji H; Maeda N; Tomoda K; Kumazawa T
Rhinol Suppl; 1989; 8():15-24. PubMed ID: 2505369
[TBL] [Abstract][Full Text] [Related]
3. [Mast cells in the nasal mucosa of patients with nasal polyps. A histological study with lectins].
Melgarejo Moreno P; Hellín Meseguer D; Sarroca Capell E
An Otorrinolaringol Ibero Am; 1998; 25(1):23-8. PubMed ID: 9542244
[TBL] [Abstract][Full Text] [Related]
4. Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis.
Jankowski R; Béné MC; Moneret-Vautrin AD; Haas F; Faure G; Simon C; Wayoff M
Rhinol Suppl; 1989; 8():51-8. PubMed ID: 2672277
[TBL] [Abstract][Full Text] [Related]
5. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis.
Sena AA; Provazzi PJ; Fernandes AM; Cury PM; Rahal P; Oliani SM
Clin Exp Allergy; 2006 Oct; 36(10):1260-7. PubMed ID: 17014434
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the degranulated and non-degranulated mast cells in nasal polyp.
Sasaki Y
Acta Otolaryngol Suppl; 1986; 430():34-8. PubMed ID: 3461683
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances concerning etiopathogenesis of nasal polyposis].
Bellioni P; Ruscito P; Bevilacqua P; Maurizi M; Larocca LM; Maggiano N; Capelli A
Acta Otorhinolaryngol Ital; 1989; 9(1):3-13. PubMed ID: 2658469
[TBL] [Abstract][Full Text] [Related]
8. Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: a morphometric study.
Pawliczak R; Kowalski ML; Danilewicz M; Wagrowska-Danilewicz M; Lewandowski A
Am J Rhinol; 1997; 11(4):257-62. PubMed ID: 9292175
[TBL] [Abstract][Full Text] [Related]
9. Etiopathogenesis of nasal polyps.
Krajina Z
Acta Med Croatica; 1993; 47(2):81-4. PubMed ID: 7505133
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of nasal polyps: an immunohistochemical approach.
Larocca LM; Maggiano N; Capelli A; Bevilacqua P; Ruscito P; Maurizi M; Bellioni P
Ann Allergy; 1989 Dec; 63(6 Pt 1):508-12. PubMed ID: 2596760
[TBL] [Abstract][Full Text] [Related]
11. Immunocompetent cells in human nasal polyps and normal mucosa.
Linder A; Karlsson-Parra A; Hirvelä C; Jonsson L; Köling A; Sjöberg O
Rhinology; 1993 Sep; 31(3):125-9. PubMed ID: 8256081
[TBL] [Abstract][Full Text] [Related]
12. Mast cells in the cytology of nasal mucosa; a quantitative and morphologic assessment and their diagnostic meaning.
Miecznik B
Ann Allergy; 1980 Feb; 44(2):106-11. PubMed ID: 7362082
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
14. Histamine, norepinephrine and serotonin content of nasal polyps.
Bumsted RM; El-Ackad T; Smith JM; Brody MJ
Laryngoscope; 1979 May; 89(5 Pt 1):832-43. PubMed ID: 449527
[TBL] [Abstract][Full Text] [Related]
15. Mast cell degranulation in nasal polyps.
Takasaka T; Kaku Y; Hozawa K
Acta Otolaryngol Suppl; 1986; 430():39-48. PubMed ID: 3526808
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
17. [Ultrastructure of endonasal polyposis].
Jahnke V
Z Laryngol Rhinol Otol; 1972 May; 51(5):323-30. PubMed ID: 5042765
[No Abstract] [Full Text] [Related]
18. Role of local immunoglobulin E specific for Alternaria alternata in the pathogenesis of nasal polyposis.
Sabirov A; Hamilton RG; Jacobs JB; Hillman DE; Lebowitz RA; Watts JD
Laryngoscope; 2008 Jan; 118(1):4-9. PubMed ID: 17989579
[TBL] [Abstract][Full Text] [Related]
19. Biogenic amines in nasal mucosa and nasal polyps.
Bumsted RM; El-Ackad T; Smith JM; Brody MJ
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(4 Pt 1):ORL-729-43. PubMed ID: 898524
[No Abstract] [Full Text] [Related]
20. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.
Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP
J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
